Nektar Therapeutics
NKTR
NKTR
201 hedge funds and large institutions have $3.44B invested in Nektar Therapeutics in 2017 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 73 increasing their positions, 70 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 199 → 201 (+2)
4% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 70
0.03% more ownership
Funds ownership: 6.33% → 6.36% (+0.03%)
Holders
201
Holding in Top 10
7
Calls
$32.8M
Puts
$13.4M
Top Buyers
| 1 | +$470M | |
| 2 | +$38.1M | |
| 3 | +$15.6M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.9M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.6M |
Top Sellers
| 1 | -$29.4M | |
| 2 | -$23.6M | |
| 3 | -$23.4M | |
| 4 |
Two Sigma Investments
New York
|
-$16.9M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$14.1M |